FERRARI, Silvia Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.165
EU - Europa 3.126
AS - Asia 2.892
SA - Sud America 382
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 15.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.086
GB - Regno Unito 1.578
SG - Singapore 893
CN - Cina 835
HK - Hong Kong 419
BR - Brasile 299
SE - Svezia 262
FI - Finlandia 250
DE - Germania 245
VN - Vietnam 245
UA - Ucraina 188
IT - Italia 177
TR - Turchia 174
FR - Francia 140
RU - Federazione Russa 122
BG - Bulgaria 65
KR - Corea 48
ID - Indonesia 40
IN - India 39
AE - Emirati Arabi Uniti 34
AR - Argentina 31
CA - Canada 30
ZA - Sudafrica 29
MX - Messico 27
BD - Bangladesh 26
NL - Olanda 21
JP - Giappone 20
PK - Pakistan 20
EC - Ecuador 19
IQ - Iraq 17
ES - Italia 14
PL - Polonia 14
IE - Irlanda 11
NP - Nepal 11
CL - Cile 10
BZ - Belize 9
CO - Colombia 9
VE - Venezuela 9
EG - Egitto 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
MY - Malesia 7
JO - Giordania 6
KE - Kenya 6
PH - Filippine 6
TH - Thailandia 6
BY - Bielorussia 5
MA - Marocco 5
RO - Romania 5
AU - Australia 4
BE - Belgio 4
CH - Svizzera 4
HU - Ungheria 4
LT - Lituania 4
TW - Taiwan 4
AZ - Azerbaigian 3
ET - Etiopia 3
EU - Europa 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
SN - Senegal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
DK - Danimarca 2
DZ - Algeria 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
MN - Mongolia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
IS - Islanda 1
LU - Lussemburgo 1
MD - Moldavia 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
TG - Togo 1
TV - Tuvalu 1
UY - Uruguay 1
ZM - Zambia 1
Totale 15.638
Salva come PNG Salva come JPEG
Città #
Southend 1.275
Fairfield 911
Santa Clara 783
Ashburn 704
Woodbridge 589
Singapore 573
Chicago 475
Hong Kong 414
Jacksonville 387
Houston 352
Seattle 334
Los Angeles 309
Chandler 296
Cambridge 282
Wilmington 279
Dearborn 225
Ann Arbor 217
San Jose 206
Salt Lake City 205
Hefei 194
Helsinki 190
Nyköping 184
Beijing 173
London 167
Izmir 113
Tampa 94
Council Bluffs 93
Elk Grove Village 92
Ho Chi Minh City 80
The Dalles 74
Princeton 70
San Diego 65
Sofia 64
Bremen 62
Modena 60
Eugene 58
Hanoi 57
New York 54
Lauterbourg 53
Dallas 51
Sterling 50
Seoul 47
Lancaster 43
Buffalo 42
Frankfurt am Main 36
São Paulo 34
Shanghai 33
Moscow 32
Dulles 29
Miami 29
Jakarta 28
Columbus 27
Detroit 26
Atlanta 25
Des Moines 25
Milan 24
Phoenix 18
Redwood City 17
Da Nang 16
Tokyo 15
Dong Ket 14
Kansas City 14
Warsaw 14
Kunming 13
Mexico City 13
Boardman 12
Brooklyn 12
Guangzhou 12
Haiphong 12
Norwalk 12
Orem 12
Chiswick 11
Curitiba 11
Dublin 11
Pittsburgh 11
Denver 10
Hounslow 10
Belize City 9
Hangzhou 9
Kilburn 9
Toronto 9
Jersey City 8
Johannesburg 8
Lahore 8
Montreal 8
Baghdad 7
Belo Horizonte 7
Delhi 7
Redondo Beach 7
San Francisco 7
Tashkent 7
Cairo 6
Kathmandu 6
Mountain View 6
Quito 6
Rio de Janeiro 6
Saint Louis 6
Tianjin 6
Acton 5
Amman 5
Totale 11.826
Salva come PNG Salva come JPEG
Nome #
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 760
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 427
Endocrine manifestations of hepatitis C virus infection. 380
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 368
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 352
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 344
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 343
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 336
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 334
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 329
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 324
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 322
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 312
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 305
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 304
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 300
Cytokines and HCV-related disorders 299
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 289
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 289
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 287
Associations between Systemic Sclerosis and Thyroid Diseases 279
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 275
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 274
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 273
CXCL10 and CCL2 Chemokine Serum Levels in Patients With Hepatitis C Associated With Autoimmune Thyroiditis 268
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 268
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 263
New targeted molecular therapies for dedifferentiated thyroid cancer 261
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 249
[CXCR3 and CXCL10 in autoimmune thyroiditis] 248
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 248
IP-10 in autoimmune thyroiditis 247
Novel Therapies for Thyroid Autoimmune Diseases 242
[Cryoglobulinemia and the α-chemokine IP-10] 235
HEPATITIS C IS ASSOCIATED WITH HIGH LEVELS OF CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND INTERLEUKIN-6 234
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists. 229
RET TKI: potential role in thyroid cancers. 225
CXCL10 in psoriasis 225
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 224
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 215
The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. 214
High Levels of Circulating Chemokine (C-X-C motif) Ligand 11 Are Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis and with Chemokine (C-X-C Motif) Ligand 10 213
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 213
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 208
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 199
α-Chemokine CXCL10 and β-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis 196
Interleukin-1beta, C-X-C Motif Ligand 10, and Interferon-Gamma Serum Levels in Mixed Cryoglobulinemia With or Without Autoimmune Thyroiditis. 191
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. 189
Extrahepatic manifestations of hepatitis C virus: the thyroid disorders 186
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine 176
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 174
Role of CXCL10 in cryoglobulinemia 170
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 170
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia 168
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 159
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 155
High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia 148
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 147
HCV-related autoimmune disorders in HCV chronic infection. 140
Mixed cryoglobulinemia and thyroid autoimmune disorders 127
Hepatitis C virus infection and type 2 diabetes. 114
Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience 111
Totale 15.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.914
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021235 0 0 0 0 0 0 0 0 0 0 151 84
2021/20221.135 53 154 194 68 8 55 72 41 96 90 190 114
2022/2023980 153 76 81 74 151 139 19 103 110 7 45 22
2023/2024640 12 37 38 120 158 25 45 62 12 37 31 63
2024/20252.262 64 13 19 188 529 376 73 124 286 205 188 197
2025/20265.092 177 144 295 958 1.690 330 466 188 439 345 60 0
Totale 15.754